Home / News

Business

  • 0

Fortis Hospital Vadapalani rolls out Sputnik V for the general public

Chennai: Today, leading hospital chain Fortis Healthcare rolled out Sputnik V as a part of a pilot soft launch, the third vaccine approved for India, for the general public at Fortis Hospital Vadapalani. Around 70 number of people got Sputnik V on the day 1 of the rollout and registration for the vaccination can be done through the COWIN and Aarogya Setu applications. The vaccine stock has been directly procured by Fortis, from Dr. Reddy’s Laboratories, as per Government guidelines and has been priced at Rs. 1,145 (as per government guidelines – inclusive of administrative charges).

 

While Fortis Hospital Vadapalani continues to administer COVISHIELD AND COVAXIN, Sputnik V is also being made available to the public. Recent trials have shown that Sputnik V, has an efficacy of over 90% and will bring down symptomatic Covid-19 cases by over 90%, making it possible for India’s large population to be safe from infection from future virus strains. Fortis Healthcare ramped up its vaccination drive since April 2021 when vaccines were opened to all age groups above 18.

 

Dr. Sanjay Pandey, Zonal Director, Fortis Hospital Vadapalani, said, “we are happy to see the interest among general public to get themselves vaccinated. This indicates that the misconceptions on COVID vaccines is evading and people are getting confident on vaccine. Fortis is actively working towards ensuring that as many Indians as possible are fully vaccinated. Till date, our unit was only providing COVAXIN and COVISHIELD, however, we are pleased to announce that Fortis Hospital Vadapalani, in collaboration with Dr. Reddy’s Laboratories, providing the third vaccine option, with the dual objective of expanding and scaling up the vaccination drive and lowering the infection risks to future mutations of the virus. We urge all the eligible citizens to get vaccinated to ensure safe India. It is essential.”

 

As a part of the phase wise pilot project, the two-dose vaccine has been successfully introduced by Fortis Healthcare at Fortis Hospital, Vadapalani.

 https://www.firstpost.com/health/russias-sputnik-v-vaccine-has-91-6-efficacy-against-covid-19-says-study-based-on-phase-3-trials-9265281.html

Previous News

Technology News

Airtel takes another step in delivering the best network for customers in Uttar Pradesh (East) Circle

Lucknow / New Delhi : Bharti Airtel (“Airtel”), India’s p

Oppo bags 12 int'l innovation award in home service including AI category

Dhaka: Leading global smartphone brand OPPO recently took part in the premier annual computer vis

Microchip Boosts Gallium Nitride (GaN) Radio Frequency (RF) Portfolio with Ka-band Monolithic Microwave Integrated Circuit (MMIC) with High Linearity for SatCom Terminals

New Delhi: Satellite communication systems use complex modulation schemes to ach

V-Guard Releases New Communication for its Long-Lasting Electricals

V-Guard, a brand, which has emerged as one of the top players in the Electricals category has jus

Latest Business News

TSSC and BIF partner for enhanced skilling in Indian Broadband ecosystem

New Delhi : The Telecom Sector Skill Council (TSSC) - India’s premier skill development institution for telec

‘You are gold’ campaign launched to allure youth towards gold jewellery

The World Gold Council today unveiled a multi-media campaign in partnership with Gem & Jewellery Export Promotion Council (GJEPC) to

Commvault Named a Leader in 2021 Gartner Magic Quadrant for Enterprise Backup and Recovery Software Solutions for 10th Consecutive Time

Bangalore, India : Today Commvault (NASDAQ: CVLT), a recognized global enterprise leader in Intelligent Data Services across on-pr